|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Pharmacology, School of Pharmacy, Hebrew University, Jerusalem, Israel;
Brookhaven National Laboratory, Upton, New York, USA;
Department of Neurology, AHEPA University Hospital, Greece;
Department of Physiology, Faculty of Medicine, Aristotle University of Thessaloniki, Greece;
|| Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel; and
¶ Department of Rehabilitation, Hadassah Medical Center, Jerusalem, Israel
1Correspondence: Department of Pharmacology, School of Pharmacy, The Hebrew University of Jerusalem, POB 12065, Jerusalem 91120, Israel. E-mail: yaka{at}md.huji.ac.il
Traumatic brain injury triggers a massive glutamate efflux, activation of NMDA receptor channels, and cell death. Recently, we reported that NMDA receptors in mice are down-regulated from hours to days following closed head injury (CHI), and treatment with NMDA improved recovery of motor and cognitive functions up to 14 d post-injury. Here we show that a single injection of a low dose of D-cycloserine (DCS), a partial NMDA receptor agonist, in CHI mice 24 h post-injury, resulted in a faster and greater recovery of motor and memory functions as assessed by neurological severity score and object recognition tests, respectively. Moreover, DCS treatment of CHI mice led to a significant improvement of hippocampal long-term potentiation (LTP) in the CA1 region that was completely blunted in CHI control mice. However, DCS did not improve CHI-induced impairment in synaptic glutamate release measured by paired pulse facilitation (PPF) ratio in hippocampal CA1 region. Finally, CHI-induced reduction of brain-derived neurotrophic factor (BDNF) was fully restored following DCS treatment. Since DCS is in clinical use for other indications, the present study offers a novel approach to treat human brain injury.Yaka, R., Biegon, A., Grigoriadis, N., Simeonidou, C., Grigoriadis, S., Alexandrovich, A. G., Matzner, H., Schumann, J., Trembovler, V., Tsenter, J., Shohami, E. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury.
Key Words: traumatic brain injury NMDA receptors synaptic plasticity BDNF
This article has been cited by other articles:
![]() |
G. Richter-Levin and M. Maroun Stress and Amygdala Suppression of Metaplasticity in the Medial Prefrontal Cortex Cereb Cortex, January 15, 2010; (2010) bhp311v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Blanke and A. M. J. VanDongen Constitutive Activation of the N-Methyl-D-aspartate Receptor via Cleft-spanning Disulfide Bonds J. Biol. Chem., August 1, 2008; 283(31): 21519 - 21529. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |